Weight Loss Patches UK: We Get the Appeal. But Here's What You Actually Need to Know.

Written by TribeTeam | 21-Apr-2026 11:55:47

They're all over TikTok, Instagram, and your group chats. No needles, no prescription, no faff. So why aren't doctors recommending them?

Quick answer

No weight loss patches are MHRA-approved in the UK. They are sold as food supplements, not medicines, and are not required to prove they work. They do not contain active GLP-1 medication, and the science does not support transdermal delivery of GLP-1 molecules. MHRA-approved options for weight loss are Wegovy, Mounjaro, and Saxenda - all prescription-only injections.

If you've been curious about weight loss patches, you're not alone - and you're not silly for wondering. When you see "GLP-1 patch" plastered across a glossy Instagram reel with a convincing before-and-after, it's natural to think: could this be a gentler way to get the same results?

We're here to give you the honest answer - not to shame the question, but because you deserve the facts. At TribElle, we're a GPhC-registered pharmacy built for women, and that means we'll always tell you the truth, even when it's not what an influencer is selling.

What are weight loss patches?

Weight loss patches are adhesive stickers - worn on the skin, usually for several hours at a time - that claim to help you lose weight. Many are marketed as "GLP-1 patches," borrowing the language of clinically approved medications like Wegovy and Mounjaro to suggest they work in a similar way.

They typically contain a mix of herbal extracts, vitamins, or plant compounds such as berberine, green tea extract, or Garcinia cambogia.[9] They do not contain actual GLP-1 medication.

The "GLP-1 patch" label is a marketing choice, not a medical classification.

Are weight loss patches MHRA approved in the UK?

The key fact

No weight loss patches are currently approved by the MHRA - the UK's official medicines regulator.[6] That means no patch on the market has been rigorously tested or proven to work for weight loss in a way that meets UK medical standards.

Patches are sold as food supplements or cosmetics - not medicines - so they sit in a completely different regulatory category. They are not required to prove they work. They are not required to disclose all ingredients. And if something goes wrong, there is very little recourse.[6]

Compare that to a licensed weight loss medicine like Wegovy or Mounjaro. Those treatments have gone through years of clinical trials, thousands of participants, and rigorous MHRA review before being approved. The evidence isn't a testimonial - it's a body of peer-reviewed scientific data.[1][2]

Patches don't go through any of that process. Which is exactly why the MHRA has repeatedly warned the public against buying unlicensed weight loss products, especially those sold online or via social media.[7]

A note on safety

Because patches aren't regulated as medicines, there is a real risk of undeclared or harmful ingredients. MHRA enforcement actions have found unlicensed weight loss products containing sibutramine - a stimulant withdrawn from the UK and European markets in 2010 due to serious cardiovascular risks, including increased risk of heart attack and stroke.[8][9]

The wrapping might look professional. The marketing might sound clinical. But without MHRA oversight, what's actually in that patch is unverified. In May 2025, the MHRA dismantled the first illicit weight loss drug factory ever discovered in the UK - stocked with raw chemical ingredients and unlicensed injectable pens ready for dispatch.[8]

Can patches deliver GLP-1 medication through the skin?

No - and this is a critical point. Even if a patch did contain an active ingredient, getting it into the bloodstream through skin is scientifically very difficult. GLP-1 molecules are large proteins. They do not pass through skin effectively. That's exactly why approved GLP-1 medications are delivered by subcutaneous injection or, in some cases, oral tablet.

A patch claiming to deliver the same effect as Wegovy or Mounjaro isn't just unproven - it's scientifically implausible given current transdermal delivery technology.[6]

"The 'GLP-1 patch' label is clever marketing, not medicine. These products borrow the credibility of a regulated drug category without earning any of it."

Why are weight loss patches everywhere on social media?

Because they sell. The combination of GLP-1 hype, social media reach, and a genuinely underserved need for affordable, accessible weight loss support creates the perfect conditions for unregulated products to flourish.

In the UK, the Advertising Standards Authority (ASA) has taken direct action against this. In August 2025, the ASA ruled against multiple brands making medicinal claims for supplements and patches - including any that implied the product works like a prescription GLP-1 medication.[10] The ASA found such ads to be "medicinal by presentation" and in breach of advertising rules, regardless of how the products were labelled or marketed.

Enforcement is slow, the internet is vast, and real people are spending real money on products that simply don't work - and in some cases, aren't safe.

By the numbers

0

weight loss patches currently approved by the MHRA.[6] Every patch on the market sits outside UK medicines regulation.

What MHRA-approved weight loss treatments are available in the UK?

The treatments that have gone through proper regulation and robust clinical testing are:

MHRA APPROVED

Wegovy (semaglutide)

A once-weekly injection. MHRA-approved for weight management. The STEP 1 clinical trial (1,961 participants, 68 weeks) showed a mean weight loss of 14.9% with semaglutide versus 2.4% with placebo.[1] A higher 7.2mg dose was MHRA-approved in January 2026, with the STEP UP trial showing mean weight loss of 21%.[5]

MHRA APPROVED

Mounjaro (tirzepatide)

A once-weekly injection working on both GLP-1 and GIP receptors. MHRA-approved for weight management since November 2023. The SURMOUNT-1 trial (2,539 participants, 72 weeks) showed mean weight loss of up to 22.5% at the 15mg dose versus 2.4% with placebo.[2]

MHRA APPROVED

Saxenda (liraglutide)

A daily GLP-1 injection. An older treatment, less commonly prescribed now given the effectiveness of newer options, but still MHRA-licensed for weight management in adults.[6]

All three are prescription-only, dispensed by GPhC-registered pharmacies, and require a clinical consultation before starting. That structure exists to protect you - not to create barriers.

What if I want a weight loss option without injections?

That's a completely understandable preference. The good news is that oral options are in development. Rybelsus (oral semaglutide) is already MHRA-approved for type 2 diabetes. A higher-dose version specifically for obesity has been in regulatory review, and phase 3 results showed weight loss of around 13.6%.[6]

These will be prescription medications, tested and regulated. Not patches. But the landscape is evolving, and non-injectable options are genuinely on the horizon.

Frequently asked questions

Are weight loss patches legal in the UK?

Yes - because they're sold as supplements or cosmetics, not medicines. Legal doesn't mean safe, and it definitely doesn't mean effective. Food supplements in the UK do not require pre-market safety or efficacy testing.

Could a patch give me the same results as Wegovy or Mounjaro?

No. Patches don't contain active GLP-1 ingredients, and current science cannot reliably deliver GLP-1 molecules through skin in a way that produces clinical results. The STEP 1 trial showed Wegovy delivering 14.9% mean weight loss[1]; SURMOUNT-1 showed Mounjaro delivering up to 22.5% weight loss.[2] No patch has evidence approaching either figure.

Are weight loss patches dangerous?

Potentially. Without MHRA oversight, ingredients aren't independently verified. MHRA enforcement actions have found banned substances like sibutramine in unlicensed slimming products - a substance withdrawn in 2010 due to serious cardiovascular risks.[8][9] The MHRA has urged people not to buy weight loss products from unregulated sources.[7]

What should I look for in a safe weight loss treatment?

Look for treatments that are MHRA-approved, prescribed by a qualified clinician (GMC-registered doctor, GPhC certified Pharmacist, or NMC prescribing nurse), and dispensed by a GPhC-registered pharmacy. All three boxes protect you in different ways.[6][7]

Why are GLP-1 patches pushed so hard on social media?

Because they're profitable and easy to sell with no prescription requirement or clinical trial obligation. The "GLP-1" label does a lot of marketing work without any of the medical burden. The ASA has ruled against brands that imply patches produce the same results as prescription GLP-1 medicines.[10]

Do weight loss patches continue to work after you stop using them?

There is no clinical evidence that patches produce meaningful weight loss in the first place, so the question of maintenance does not arise. In contrast, research shows that people who stop MHRA-approved GLP-1 medications do regain a significant portion of weight, which is why ongoing clinical support matters.[3][4]

The bottom line

Curiosity about patches makes complete sense. The injections feel daunting, the costs feel high, and the social media content is relentless. Of course you'd wonder if there's an easier way.

But the honest answer is: no patch on the UK market is MHRA-approved, none contain real GLP-1 medication, and the science doesn't support skin delivery of GLP-1 molecules anyway.

If weight loss treatment is something you're exploring, you deserve options that have actually been tested - not products that borrow the language of medicine without any of the accountability. The approved treatments exist. They work. And they're accessible through regulated pharmacies like TribElle, with clinical support built in.

References

Clinical studies

  1. Wilding JPH, et al. (2021). Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 384, 989-1002.
    nejm.org/doi/full/10.1056/NEJMoa2032183
  2. Jastreboff AM, et al. (2022). Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine, 387(3), 205-216.
    nejm.org/doi/full/10.1056/NEJMoa2206038
  3. Rubino D, et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance (STEP 4). JAMA, 325, 1414-1425.
    jamanetwork.com/journals/jama/fullarticle/2777886
  4. Wilding JPH, et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: STEP 1 trial extension. Diabetes, Obesity and Metabolism.
    dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14725
  5. Aronne LJ, et al. (2025). Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). New England Journal of Medicine, 393(1).
    nejm.org/doi/full/10.1056/NEJMoa2416394

Regulatory sources

  1. MHRA / GOV.UK (2026). GLP-1 medicines for weight loss and diabetes: what you need to know.
    gov.uk - GLP-1 medicines for weight loss and diabetes
  2. MHRA / GOV.UK (December 2025). MHRA urges public to avoid illegal online weight-loss medicines this New Year.
    gov.uk - MHRA warns against illegal online weight-loss medicines
  3. MHRA / GOV.UK (October 2025). MHRA smashes major illicit weight loss medicine production facility in record seizure.
    gov.uk - MHRA record seizure of illicit weight loss medicines
  4. MHRA / GOV.UK (2015). MHRA seize huge haul of potentially dangerous slimming pills.
    gov.uk - MHRA seizure of dangerous slimming pills

Advertising standards

  1. ASA / CAP (2025). Weight control: pills, medicines and patches - advice for advertisers.
    asa.org.uk - weight control advertising advice

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any weight loss treatment. TribElle is a GPhC-registered online pharmacy (Reg. 9012688). Last reviewed: April 2026.